Early plasma exposure after a first dose of ribavirin in HIV-HCV coinfected patients compared with HCV monoinfected patients

被引：0
|
作者：
Hatu, Giorgiana [1 ]
Pradat, Pierre [1 ]
Pourcelot, Emmanuel [2 ]
Maynard-Muet, Marianne [1 ]
Bailly, Francois [1 ]
Miailhes, Patrick [1 ]
Zoulim, Fabien [1 ]
Gagnieu, Marie-Claude [2 ]
机构：
[1] Hop Croix Rousse, Hosp Civils Lyon, F-69317 Lyon, France
[2] Hop Edouard Herriot, Hosp Civils Lyon, Lyon, France
来源：
HEPATOLOGY | 2013年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1917
引用
收藏
页码：1134A / 1134A
页数：1
相关论文
共 50 条
  • [31] Hepatitis C treatment initiation in HIV-HCV coinfected patients
    Laurent Cotte
    Pascal Pugliese
    Marc-Antoine Valantin
    Lise Cuzin
    Eric Billaud
    Claudine Duvivier
    Alissa Naqvi
    Antoine Cheret
    David Rey
    Pierre Pradat
    Isabelle Poizot-Martin
    BMC Infectious Diseases, 16
  • [32] Predictive value of early virological response (12 weeks) to pegylated interferon plus ribavirin in HIV-HCV coinfected patients
    Perez-Olmeda, M
    Martin-Carbonero, L
    Romero, M
    Rios, P
    Nunez, M
    Soriano, V
    Garcia-Samaniego, J
    JOURNAL OF HEPATOLOGY, 2003, 38 : 163 - 163
  • [33] Aggressive daily interferon therapy in HIV-HCV coinfected patients
    Bruno, R
    Sacchi, P
    Filice, C
    Filice, G
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000, 25 (04) : 372 - 373
  • [34] HCV-RNA DECLINE IN THE FIRST 48 HOURS IDENTIFIES HCV MONOINFECTED AND HCV/HIV COINFECTED PATIENTS WITH RVR AT WEEK 4 OF PEGINTERFERON-ALPHA-2A/RIBAVIRIN THERAPY
    Arends, J. E.
    Stuart, J. Cohen
    Baak, L. C.
    van der Ende, M. E.
    van Erpecum, K. J.
    Boland, G. J.
    van Baarle, D.
    Hoepelman, I. M.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S123 - S123
  • [35] Histological lesions and intrahepatic HCV detection in HIV-HCV coinfected patients, before and after anti-HCV treatment.
    Le Bail, B
    Rullier, A
    Trimoulet, P
    Neau, D
    Urbaniak, R
    Ballardini, G
    Lafon, ME
    Bioulac-Sage, P
    HEPATOLOGY, 2002, 36 (04) : 564A - 564A
  • [36] Efficacy and tolerability of DAAs in HCV-monoinfected and HCV/HIV-coinfected patients with psychiatric disorders
    Nicolò de Gennaro
    Lucia Diella
    Laura Monno
    Gioacchino Angarano
    Michele Milella
    Annalisa Saracino
    BMC Infectious Diseases, 20
  • [37] HCV viral recurrence and liver mitochondrial damage after liver transplantation (LT) in HIV-HCV coinfected patients
    Duclos-Vallee, JC
    Vittecoq, D
    Teicher, E
    Feray, C
    Roque-Afonso, AM
    Lombes, A
    Jardel, C
    Gigou, M
    Dussaix, E
    Guettier, C
    Sebagh, M
    Azoulay, D
    Adam, R
    Ichai, P
    Saliba, F
    Roche, B
    Castaing, D
    Samuel, D
    JOURNAL OF HEPATOLOGY, 2004, 40 : 44 - 44
  • [38] Efficacy and tolerability of DAAs in HCV-monoinfected and HCV/HIV-coinfected patients with psychiatric disorders
    de Gennaro, Nicolo
    Diella, Lucia
    Monno, Laura
    Angarano, Gioacchino
    Milella, Michele
    Saracino, Annalisa
    BMC INFECTIOUS DISEASES, 2020, 20 (01)
  • [39] Timing of treatment initiation of direct-acting antivirals for HIV/HCV coinfected and HCV monoinfected patients
    Rice, Donald P.
    Ordoveza, Michelle A.
    Palmer, Ann M.
    Wu, George Y.
    Chirch, Lisa M.
    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2018, 30 (12): : 1507 - 1511
  • [40] Hcv dynamics in HIV/HCV coinfected patients treated with pegylated interferon and ribavirin.
    Talal, AH
    Shata, MT
    Flynn, SM
    Dorante, G
    Laughlin, M
    Ribeiro, RM
    Perelson, AS
    HEPATOLOGY, 2002, 36 (04) : 205A - 205A
12345